Newsletter | April 5, 2024

04.05.24 -- Process Development: Stuck In The Middle With You

FEATURED EDITORIAL

Process Development: Stuck In The Middle With You

There is pressure to accelerate programs out of research, and into development. Then, despite the complexity of new drugs, therapies and technologies, process development chemists are asked to quick-step to clinical grade, and commercial-ready material. For their part, CDMOs need to react to it all.

A Structured Approach To Regulatory Information Management Vendor Selection

Deploying a formal system for regulatory information management is a given now for all life sciences companies, irrespective of their size and focus. Regulators expect this, particularly as data rather than static documents evolves to become the default.

INDUSTRY INSIGHTS

Critical Supply Strategies For CROs

Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy.

Rapid Development Of Amorphous Solid Dispersions For Bioavailability

See how an amorphous solid dispersion (ASD) of acalabrutinib was designed using in vitro studies and in silico modeling. Understand how ASD formulations can enhance bioavailability.

Intro to USP <1062> — What is Tabletability?

What is tabletability and why is it important for creating tablets that can survive the journey from manufacturing to packaging?

Create Amorphous Solid Dispersions Using Hot Melt Extrusion

ASDs improve bioavailability to provide acceptable in vivo performance, but production requires an enabling technology. Spray drying and hot melt extrusion are among the most widely applied.

Pinpoint Manufacturing Steps That Require Tighter Control

With a complete picture of the parameters that control each step during manufacturing, chemists can monitor and control individual reactions to optimize the production process.

SOLUTIONS

Improve The Bioavailability Of Poorly Soluble Drugs

KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies in a fraction of the time of other amorphous solid dispersion technologies.

Solid Form Services

We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: